Assessing violence risk in first-episode psychosis: external validation, updating and net benefit of a prediction tool (OxMIV). (2023)
Attributed to:
Identifying the prevalence of antibodies to neuronal membrane targets in first episode psychosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjment-2022-300634
PubMed Identifier: 37316256
Publication URI: http://europepmc.org/abstract/MED/37316256
Type: Journal Article/Review
Volume: 26
Parent Publication: BMJ mental health
Issue: 1
ISSN: 2755-9734